Sébastien RICHARD

• HBsAg Suppression by a New Series of HBV RNA Destabilizers: Discovery and Effects on In Vitro Neurite Outgrowth, 2026, J.Med.Chem., publication
• Synthesis of Heterocyclic compounds and their application, 2020, 3 patents, GALAPAGOS, patent, as inventor (2020-2021)
• Synthesis of β-lactamase inhibitors, 2016, 6 patents, MUTABILIS, patent, as inventor (2016-2018)
• Synthesis, radiolabeling with fluorine-18 and preliminary in vivo evaluation of a heparan sulphate mimetic as potent angiogenesis and heparanase inhibitor for cancer applications, 2016, Org. Biomol. Chem., publication
• Synthesis and Biological Evaluation of a Unique Heparin Mimetic Hexasaccharide for SAR Studies, 2014, J. Med. Chem., publication
• Synthesis, in vitro Evaluation and Radiolabeling with Fluorine-18 of Heparan Sulphate Mimetic as Potent Angiogenesis and Heparanase inhibitor for cancer Imaging and therapy, 2013, Comm. Bioconj. Chem., publication
• Synthesis of a stable-isotope labeled biotinylated pentasaccharide conjugate (EP217609), a dual effect anticoagulant drug, 2011, J. Label. Comp. Radiopharm., publication
• A New Synthesis of Opticaly Active 3-Substitued (3S)-3,4-Dihydro-5-(perfluoroalkyl)-2H-[1,4]oxazepin-7-ones, 2003, Helvetica Chimica Acta., publication
• Easy synthesis of (E)- or (Z)- Perfluorinated β-enaminoesters, 2002, Journal of Fluorine Chemistry, publication

Musique, cinéma et astronomie